Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/04/2003WO2002101068A3 Process for the preparation of d-pantothenic acid and/or salts thereof
09/04/2003WO2002101062A3 Process for the preparation of d-pantothenic acid and/or salts thereof
09/04/2003WO2002101044A3 Brain expressed gene and protein associated with bipolar disorder
09/04/2003WO2002101017A3 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
09/04/2003WO2002099107A3 Regulation of human trace amine receptor ta5
09/04/2003WO2002097395A3 P-cadherin as a target for anti-cancer therapy
09/04/2003WO2002096947A3 The lectin-like domain of thrombomodulin and its therapeutic use
09/04/2003WO2002094870A8 Proteins and nucleic acids encoding same
09/04/2003WO2002089973A3 Affinity reaction probe detection/analysis chips and detection system and apparatus using the same
09/04/2003WO2002083886A3 Means and method for the preparation of transgenic plants resistant to viral infections
09/04/2003WO2002083858A8 Methods to inhibit viral replication
09/04/2003WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins
09/04/2003WO2002081749A3 Detection of aberrant dna methylation as marker for human cancer
09/04/2003WO2002081695A3 Genes that are modulated by posttranscriptional gene silencing
09/04/2003WO2002081647A3 Bioluminescent plants and methods of making same
09/04/2003WO2002079465A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
09/04/2003WO2002079424A3 TRANSGENIC MICE CONTAINING β3GALT2 GENE DISRUPTIONS
09/04/2003WO2002079248A3 Mammalian alpha-helical protein-53
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002074795A3 Oligomeric complexes of chimeric proteins with enhanced immunogenic potential
09/04/2003WO2002072804A3 Novel genes for conditional cell ablation
09/04/2003WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof
09/04/2003WO2002070703A3 Cell visual characteristic-modifying sequences
09/04/2003WO2002066952A3 Mass defect labeling for the determination of oligomer sequences
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002062823A3 Peptides for facilitating composite receptor expression and translocation of macromolecules
09/04/2003WO2002061079A3 Biligands
09/04/2003WO2002061042A3 Genetic control of organ abscission
09/04/2003WO2002061041A3 Solubility reporter gene constructs
09/04/2003WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof
09/04/2003WO2002059336A3 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
09/04/2003WO2002059320A3 Dna sequences of escherichia coli cft073
09/04/2003WO2002059313A3 G-protein coupled receptors and nucleic acids encoding same
09/04/2003WO2002057436A3 Red blood cell from a transgenic animal as vehicle for polypeptide delivery
09/04/2003WO2002055742A3 Rapid method for screening compounds for in vivo activity
09/04/2003WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation
09/04/2003WO2002054083A3 Alpha synuclein aggregation assays
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002053699A3 Chondrocyte-specific and non-specific elements in the fgfr-3 promoter region
09/04/2003WO2002052020A3 Regulation of human carboxypeptidase a
09/04/2003WO2002052002A3 Immunomodulatory polynucleotides and methods of using the same
09/04/2003WO2002047479A3 Cloning bovines by nuclear transplantation
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002046413A3 Molecules for disease detection and treatment
09/04/2003WO2002046389A3 Genes associated with allergic hypersensitivity and mast cell activation
09/04/2003WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide
09/04/2003WO2002046220A3 Sequences upstream of the carp gene, vectors containing them and uses thereof
09/04/2003WO2002044421A3 Reverse transcription reactions
09/04/2003WO2002038767A3 G protein-coupled receptor protein and nucleic acid molecules and uses therefor
09/04/2003WO2002036807A3 Compositions and methods relating to breast specific genes and proteins
09/04/2003WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
09/04/2003WO2002034923A9 Monocotyledon plant cells and plants which synthesise modified starch
09/04/2003WO2002034042A3 Knockout mice thyroid stimulating hormone receptor (tsh-r) gene
09/04/2003WO2002033109A3 Fermentation method for production of heterologous gene products in lactic acid bacteria
09/04/2003WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
09/04/2003WO2002031166A3 Artificial transcriptional factors and methods of use
09/04/2003WO2002024893A3 CHARACTERIZATION OF THE GSK-3β PROTEIN AND METHODS OF USE THEREOF
09/04/2003WO2002022667A3 Twin-arginine translocation in bacillus
09/04/2003WO2002020769A9 Human and mouse targeting peptides identified by phage display
09/04/2003WO2002018643A3 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/04/2003WO2002016432A3 Two receptors of meiosis activating sterols designated sam1a and sam1b
09/04/2003WO2002016421A9 Altered ospa of borrelia burgdorferi
09/04/2003WO2002010458A3 Method of performing subtractive hybridization
09/04/2003WO2002008456A3 Method for identifying metastatic tumor cells
09/04/2003WO2002002808A3 Method and nucleic acids for the analysis of astrocytomas
09/04/2003WO2002000932A3 Diagnosis of known genetic parameters within the mhc
09/04/2003WO2001096605A3 Methods of dissociating nongenotropic from genotropic activity of steroid receptors
09/04/2003WO2001094629A3 Cancer gene determination and therapeutic screening using signature gene sets
09/04/2003WO2001092299A3 Adenovirus particles with mutagenized fiber proteins
09/04/2003WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
09/04/2003WO2001081622A3 Diagnosis of diseases associated with dna repair
09/04/2003WO2001076451A3 Diagnosis of diseases associated with metabolism
09/04/2003WO2001066799A3 Real time quantitative pcr with intercalating dye for single and multiplex target dna
09/04/2003WO2001066595A9 Human fgf-23 gene and gene expression products
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030167544 Low lipoxygenase 1 barley
09/04/2003US20030167539 Genetically modified plants having modulated flower development
09/04/2003US20030167538 Genetic engineered plants; corn, wheat, rice
09/04/2003US20030167537 Genetic engineered polynucleotide; adjusting transcription factor
09/04/2003US20030167536 Plant adpglucose pyroghophatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants
09/04/2003US20030167535 Comprises farnesyl transferases
09/04/2003US20030167534 Method of producing heteromultimeric mammalian proteins in plants
09/04/2003US20030167533 Intein-mediated protein splicing
09/04/2003US20030167532 OAR polynucleotides, polypeptides and their use in PHA production in plants
09/04/2003US20030167531 Cytokines; growth hormone; granulocyte colony stimulating factor
09/04/2003US20030167530 Polpeptides have pyrimidine dimer excision activity; for creating male sterile plants or seedless fruits
09/04/2003US20030167529 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch
09/04/2003US20030167528 Lyases; replicating libraries; transgenic plants
09/04/2003US20030167527 Transgenic plant; genetic engineering
09/04/2003US20030167526 Comprises introducing anthocyanin polynucleotides into target cells; corn; soybeans
09/04/2003US20030167525 Desaturase genes and uses thereof
09/04/2003US20030167524 Methods for the production of multimeric protein complexes, and related compositions
09/04/2003US20030167523 Adjust oil concentration in seeds; genetic engineering
09/04/2003US20030167522 Obtained from Bacillus thuringiensis (cry proteins); for activity against corn rootworm pests
09/04/2003US20030167521 Genetic engineered insecticide
09/04/2003US20030167520 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins
09/04/2003US20030167519 Chimeric gene encoding drosomycin, vector containing it and production of disease-resistant transgenic plants
09/04/2003US20030167518 From the Ipomoea batatas plant; directs gene expression in tubers and responds in aerial structures to wounding, pathogens, and other stresses
09/04/2003US20030167517 Cry proteins for recombination within plant cells
09/04/2003US20030167516 Calcium dependent protein kinase polypeptides as regulators of plant disease resistance
1 ... 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 ... 4023